Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: The Italian cooperative group on AIDS and tumors activity

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 19, 2015, Pages 3619-3634

  Berretta, M ^a   Martellotta, F ^a   Di Francia, R ^b   Spina, M ^a   Vaccher, E ^a   Balestreri, L ^a   Borsatti, E ^a   Bearz, A ^a   De Paoli, P ^a   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cancer; Chemotherapy; Clinical aspects; HIV; NADCs; Treatment

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANUS CANCER; ARTICLE; CANCER PATIENT; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PANCREAS CANCER; POPULATION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TESTIS CANCER; ACQUIRED IMMUNODEFICIENCY SYNDROME; AGED; ANUS NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, SQUAMOUS CELL; HIV INFECTIONS; HIV SEROPOSITIVITY; ITALY; LIVER NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASMS; PROCEDURES; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, SQUAMOUS CELL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HODGKIN DISEASE; HUMANS; ITALY; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84958044481     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (110)

1. PINZONE MR, FIORICA F, DI ROSA M, MALAGUARNERA G, MALAGUARNERA L, CACOPARDO B, ZANGHÌ G, NUNNARI G. Non-AIDS-defining cancer s among HIV-infected people. Eur Rev Med Pharmacol Sci 2012;16:1377-1388.
2. SIMARD EP, ENGELS EA. Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis 2010;51:957-962.
3. MARTELLOTTA F, BERRETTA M, VACCHER E, SCHIOPPA O, ZANET E, TIRELLI U. AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies. Curr HIV Res 2009;7:634-638.
4. BERRETTA M, CINELLI R, MARTELLOTTA F, SPINA M, VACCHER E, TIRELLI U. Therapeutic approaches to AIDS related malignancies. Oncogene 2003;22:6646-6659.
5. NASTI G, MARTELLOTTA F, BERRETTA M, MENA M, FASAN M, DI PERRI G, TALAMINI R, PAGANO G, MONTRONI M, CINELLI R, VACCHER E, D'ARMINIO MONFORTE A, TIRELLI U; GICAT; ICONA. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 2003;98:2440-2446.
6. ENGELS EA, PFEIFFER RM, GOEDERT JJ, VIRGO P, MCNEEL TS, SCOPPA SM, BIGGAR RJ; HIV/AIDS Cancer Match Study. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006;20:1645-1654.
7. NUNNARI G, BERRETTA M, PINZONE MR, DI ROSA M, BERRETTA S, CUNSOLO G, MALAGUARNERA M, COSENTINO S, DE PAOLI P, SCHNELL JM, CACOPARDO B. Hepatocellular carcinoma in HIV positive patients. Eur Rev Med Pharmacol Sci 2012;16:1257-1270.
8. MANI D, HAIGENTZ M, ABOULAFIA DM. Lung Cancer in HIV Infection. Clinical Lung Cancer 2012;13:6-13.
9. CARBONE A, GLOGHINI A, VACCHER E, DE PAOLI P. Lymphomas and other cancers in HIV-infected patients WCRJ 2014;1:e291.
10. FONTANA DEL VECCHIO R, PINZONE MR, CACOPARDO B, NUNNARI G. Anal cancer in HIV-positive patients WCRJ 2014;1:e405.
11. ZANET E, BERRETTA M, DI BENEDETTO F, SIMONELLI C, BEARZ A, MORRA A, BONANNO S, BERRETTA S, TIRELLI U. Pancreatic cancer in HIV-positive patients: a clinical case-control study. Pancreas 2012;41:1331-1335.
12. SILVERBERG MJ, CHAO C, LEYDEN WA, XU L, HORBERG MA, CHAO CR, TOWNER WJ, HURLEY LB, QUESENBERRY C P JR, KLEIN DB. HIV infection and the risk of cancers with and without a known infectious cause. AIDS 2009;23:2337-2345.
13. PATEL P, HANSON DL, SULLIVAN PS, NOVAK RM, MOORMAN AC, TONG TC, HOLMBERG SD, BROOKS JT; Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008;148:728-736.
14. ENGELS EA, BROCK MV, CHEN J, HOOKER CM, GILLISON M, MOORE RD. Elevated incidence of lung cancer among HIV-infected Individuals. J Clin Oncol 2006;24:1383-1388.
15. MARTELLOTTA F, SCHIOPPA O, CACOPARDO B, FISICHELLA R, TIRELLI U. Current status and perspectives of AIDS-related Kaposis's sarcoma in the c-ART era WCRJ 2014;1:e393.
16. BURGI A, BRODINE S, WEGNER S, MILAZZO M, WALLACE MR, SPOONER K, BLAZES DL, AGAN BK, ARMSTRONG A, FRASER S, CRUM NF. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 2005;104:1505-1511.
17. CLIFFORD GM, POLESEL J, RICKENBACH M, DAL MASO L, STEFFEN I, LEDERGERBER B, RAUCH A, PROBST-HENSCH NM, BOUCHARDY C, LEVI F, FRANCESCHI S; SWISS HIV COHORT. Cancer Risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97:425-432.
18. COOLEY TP. Non-AIDS-defining cancer in HIV infected people. Hematol Oncol Clin N Am 2003;17:889-899.
19. BERRETTA M, DI BENEDETTO F, BEARZ A, SIMONELLI C, MARTELLOTTA F, DEL BEN C, BERRETTA S, SPINA M, TIRELLI U. FOLFOX-4 Regimen with concomitant HAART in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature. Cancer Invest 2008;26:610-614.
20. ZANET E, BERRETTA M, MARTELLOTTA F, CACOPARDO B, FISICHELLA R, TAVIO M, BERRETTA S, TIRELLI U. Anal cancer: focus on HIV-positive patients in the HAART era. Curr HIV Res 2011;9:70-81.
21. D'SOUZA G, WILEY DJ, LI X, CHMIEL JS, MARGOLICK JB, CRANSTON RD, JACOBSON LP. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008;48:491-499.
22. GRULICH AE, VAN LEEUWEN MT, FALSTER MO, VAJDIC CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370:59-67.
23. SHIELS MS, COLE SR, KIRK GD, POOLE C. A metaanalysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009;52:611-622.
24. WATSON AJ, SMITH BB, WHITEHEAD MR, SYKES PH, FRIZELLE FA. Malignant progression of anal intraepithelial neoplasia. ANZ J Surg 2006;76:715-717.
25. MARTELLOTTA F, BERRETTA M, CACOPARDO B, FISICHELLA R, SCHIOPPA O, ZANGHÌ A, SPARTÀ D, CAPPELLANI A, TALAMINI R, IZZI I, RIDOLFO A, TORRESIN A, FIORICA F, TIRELLI U. Clinical presentation and autcome of squamous cell carcinoma of the anus in HIV-infected patients in the HAART-era: a GICAT experience. Eur Rew Med Pharmacol Sci 2012;16:1283-1291.
26. MAGGARD MA, BEANES SR, KO CY. Anal canal cancer: a population based reappraisal. Dis Colon Rectum 2003;46:1517-1523.
27. DI FRANCIA R, DI PAOLO M, VALENTE D, CACOPARDO B, CILENTI L. Pharmacogenetic based drug-drug interactions between Highly Active Antiretroviral Therapy (HAART) and antiblastic chemotherapy WCRJ 2014;1:e386.
28. BEARZ A, VACCHER E, TALAMINI R, BERRETTA M, TIRELLI U. Comment on lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer 2012;106:1899-1900.
29. BURKHALTER JE, SPRINGER CM, CHHABRA R, OSTROFF JS, RAPKIN BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res 2005;7:511-522.
30. CENTERS FOR DISEASE CONTROL AND PREVENTION. Vital Signs: Current Cigarette Smoking Among Adults Aged-18 Years-United States, 2009. MMWR 2010;59:1135-1140.
31. DAL MASO L, POLESEL J, SERRAINO D, FRANCESCHI S. Lung cancer in persons with AIDS in Italy, 1985-1988 HIV. AIDS 2003;17:2117-2119.
32. TIRELLI U, SPINA M, SANDRI S, SERRAINO D, GOBITTI C, FASAN M, SINICCO A, GARAVELLI P, RIDOLFO AL, VACCHER E. Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer 2000;88:563-569.
33. POWLES T, NELSON M, BOWLER M. HIV-related lung cancer - a growing concern? Int J STD AIDS 2003;14:647-651.
34. BEARZ A, VACCHER E, MARTELLOTTA F, SPINA M, TALAMINI R, LLESHI A, CACOPARDO B, NUNNARI G, BERRETTA M, TIRELLI U; Italian Cooperative Group on AIDS and Tumors. Lung cancer in HIV positive patients: the GICAT experience. Eur Rev Med Pharmacol Sci 2014;18:500-508.
35. BERRETTA M, CAPPELLANI A, DI BENEDETTO F, LLESHI A, TALAMINI R, CANZONIERI V, ZANET E, BEARZ A, NASTI G, LACCHIN T, BERRETTA S, FISICHELLA R, BALESTRERI L, TORRESIN A, IZZI I, ORTOLANI P, TIRELLI U. Clinical presentation and outcome of colorectal cancer in HIVpositive patients: a clinical case-control study. Onkologie 2009;32:319-324.
36. BERRETTA M, GARLASSI E, CACOPARDO B, CAPPELLANI A, GUARALDI G, COCCHI S, DE PAOLI P, LLESHI A, IZZI I, TORRESIN A, DI GANGI P, PIETRANGELO A, FERRARI M, BEARZ A, BERRETTA S, NASTI G, DI BENEDETTO F, BALESTRERI L, TIRELLI U, VENTURA P. Hepatocellular carcinoma in HIV-infected patients: check early; treat hard. Oncologist 2011;16:1258-1269.
37. BEARZ A, GARASSINO I, CAVINA R, FAVARETTO A, BOCCALON M, TALAMINI R, BERRETTA M, SPAZZAPAN S, SIMONELLI C, SANTORO A, TIRELLI U. Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.. Lung Cancer 2008;60:240-245..
38. SOCINSKI M. The role of chemotherapy in the treatment of unresectable stage III and IV non small cell lung cancer. Respir Care Clin N Am 2003;9:207-236.
39. BEARZ A, LLESHI A, PERIN T, FRATINO L, VENTURINI S, GIACALONE A, SARTOR I, BERRETTA M, SULFARO S, TIRELLI U. Small cell lung cancer in a elderly patient: efficacy of somatostatin analog treatment. A case report. Onkologie 2011;34:117-120.
40. BEDIMO R, CHEN RY, ACCORT NA, RAPER JL, LINN C, ALLISON JJ, DUBAY J, SAAG MS, HOESLEY CJ. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis. 2004;39:1380-1384.
41. BONNET F, LEWDEN C, MAY T, HERIPRET L, JOUGLA E, BEVILACQUA S, COSTAGLIOLA D, SALMON D, CHÊNE G, MORLAT P. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004;101:317-324.
42. LEVINE AM. AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst 1993;85:1382-1397.
43. JEMAL A, SIEGEL R, XU J, WARD E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
44. YEGUEZ JF, MARTINEZ SA, SANDS DR, SANDS LR, HELLINGER MD. Colorectal malignancies in HIV positive patients. Am Surg 2003;69:981-987.
45. CHAPMAN C, ABOULAFIA DM, DEZUBE BJ, PANTANOWITZ L. Human Immunodeficiency Virus-associated adenocarcinoma of the colon: clinicopathologic findings and outcome. Clin Colorectal Cancer 2009;8:215-219.
46. BERRETTA M, TIRELLI U. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol 2006;101:907.
47. REINHOLD JP, MOON M, TENNER CT, POLES MA, BINI EJ. Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention. Am J Gastroenterol 2005;100:1805-1812.
48. BERRETTA M, LLESHI A, CAPPELLANI A, BEARZ A, SPINA M, TALAMINI R, CACOPARDO B, NUNNARI G, MONTESARCHIO V, IZZI I, LANZAFAME M, NASTI G, BASILE F, BERRETTA S, FISICHELLA R, SCHIANTARELLI CC, GARLASSI E, RIDOLFO A, GUELLA L, TIRELLI U. Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection. Curr HIV Res 2010;8:218-222.
49. BINI EJ, GREEN B, POLES MA. Screening colonoscopy for the detection of neoplastic lesions in asymptomatic HIV-infected subjects. Gut 2009;58:1129-1134.
50. BERRETTA M, MARTELLOTTA F, SIMONELLI C, DI BENEDETTO F, DE RUVO N, DRIGO A, BEARZ A, SPINA M, ZANET E, BERRETTA S, TIRELLI U. Cetuximab/targeted chemotherapy in an HIV-positive patient with metastatic colorectal cancer in the HAART era: a case report. J Chemother 2007;19:343-346.
51. BERRETTA M, LLESHI A, ZANET E, BEARZ A, SIMONELLI C, FISICHELLA R, NASTI G, BERRETTA S, TIRELLI U. Bevacizumab plus irinotecan-, fluorouracil-, and leucovorinbased chemotherapy with concomitant HAART in an HIV-positive patient with metastatic colorectal cancer. Onkologie 2008;31:394-397.
52. BERRETTA M, DI BENEDETTO F, SIMONELLI C, BEARZ A, BERRETTA S, MAUGERI D, TIRELLI U. Multidisciplinary approach in a HIV/HCV-positive patient with liver metastases by colorectal cancer in the HAART era. Ann Oncol 2006;17:1333-1334.
53. ALTAVILLA G, CAPUTO A, LANFREDI M, PIOLA C, BARBANTI-BRODANO G, CORALLINI A. Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene. Am J Pathol 2000;157:1081-1089.
54. GIORDANO TP, KRAMER JR, SOUCHEK J, RICHARDSON P, EL-SERAG HB. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med 2004;164:2349-2354.
55. GUIGUET M, BOUE F, CADRANEL J, LANG JM, ROSENTHAL E, COSTAGLIOLA D; Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort. Clinical epidemiology group of the FHDH-ANRS CO4 cohort. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDHANRS CO4): a prospective cohort study. Lancet Oncol 2009;10:1152-1159.
56. BABU CK, SUWANSRINON K, BREN GD, BADLEY AD, RIZZA SA. HIV induces TRAIL sensitivity in hepatocytes. PLoS One 2009;4:e4623.
57. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000;283:74-80.
58. PINEDA JA, ROMERO-GÓMEZ M, DÍAZ-GARCÍA F, GIRÓNGONZÁLEZ JA, MONTERO JL, TORRE-CISNEROS J, ANDRADE RJ, GONZÁLEZ-SERRANO M, AGUILAR J, AGUILARGUISADO M, NAVARRO JM, SALMERÓN J, CABALLEROGRANADO FJ, GARCÍA-GARCÍA JA; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas; Grupo Andaluz para el Estudio del Hígado. HIV coinfection shortens the survival of patients with hepatitis C-virus-related decmpensated cirrhosis. Hepatology 2005;41:779-789.
59. PUOTI M, BRUNO R, SORIANO V, DONATO F, GAETA GB, QUINZAN GP, PRECONE D, GELATTI U, ASENSI V, VACCHER E; HIV HCC Cooperative Italian-Spanish Group. Hepatocellular carcinoma in HIV-infected patients: Epidemiological features, clinical presentation and outcome. AIDS 2004;18:2285-2293.
60. BRAU N, FOX RK, XIAO P, MARKS K, NAQVI Z, TAYLOR LE, TRIKHA A, SHERMAN M, SULKOWSKI MS, DIETERICH DT, RIGSBY MO, WRIGHT TL, HERNANDEZ MD, JAIN MK, KHATRI GK, STERLING RK, BONACINI M, MARTYN CA, AYTAMAN A, LLOVET JM, BROWN ST, BINI EJ; Nor th American Liver Cancer in HIV Study Group. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a USCanadian multicenter study. J Hepatol 2007;47:527-537.
61. GARCIA-SAMANIEGO J, RODRIGUEZ M, BERENGUER J, RODRÍGUEZ-ROSADO R, CARBÓ J, ASENSI V, SORIANO V. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001;96:179-183.
62. DI BENEDETTO F, DI SANDRO S, DE RUVO N, BERRETTA M, MONTALTI R, GUERRINI GP, BALLARIN R, DE BLASIIS MG, SPAGGIARI M, SMERIERI N, IEMMOLO RM, GUARALDI G, GERUNDA GE. Human immunodeficiency virus and liver transplantation: our point of view. Transplant Proc 2008;40:1965-1971.
63. DI BENEDETTO F, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, DI SANDRO S, BALLARIN R, CODELUPPI M, GUARALDI G, GERUNDA GE. Hepatocellular carcinoma in HIV patients treated by liver transplantation. Eur J Surg Oncol 2008;34:422-427.
64. DI BENEDETTO F, DE RUVO N, BERRETTA M, MASETTI M, MONTALTI R, DI SANDRO S, QUINTINI C, CODELUPPI M, TIRELLI U, GERUNDA GE. Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era. J Clin Oncol. 2006 10;24:e26-27.
65. TAVIO M, GROSSI P, BACCARANI U, SCUDELLER L, PEA F, BERRETTA M, ADANI G, VIVARELLI M, RIVA A, TIRELLI U, BRESADOLA V, VIALE P, RISALITI A. HIV-infected patients and liver transplantation: who, when and why. Curr HIV Res 2011;9:120-127.
66. BERRETTA M, ZANET E, DI BENEDETTO F, SIMONELLI C, BEARZ A, MORRA A, BONANNO S, BERRETTA S, TIRELLI U. Unusual presentation of metastatic hepatocellular carcinoma in an HIV/HCV coinfected patient: case report and review of the literature. Tumori 2008;94:589-591.
67. URSINO S, GRECO C, CARTEI F, COLOSIMO C, STEFANELLI A, CACOPARDO B, BERRETTA M, FIORICA F. Radiotherapy and hepatocellular carcinoma: update and review of the literature. Eur Rev Med Pharmacol Sci 2012;16:1599-604.
68. BERRETTA M, DI BENEDETTO F, DAL MASO L, CACOPARDO B, NASTI G, FACCHINI G, BEARZ A, SPINA M, GARLASSI E, DE RE V, FIORICA F, LLESHI A, TIRELLI U. Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients. Anticancer Drugs 2013;24:212-218.
69. AHLGREN JD. Epidemiology and risk factors in pancreatic cancer. Semin Oncol. 1996;23:241-250
70. JEMAL A, SIEGEL R, WARD E, WINCHESTER DP. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
71. SENER SF, FREMGEN A, MENCK HR, WINCHESTER DP. Pancreatic cancer: a report of treatment and survival trends for 100, 313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999;189:1-7.
72. YEO TP, HRUBAN RH, LEACH SD, ET AL. Pancreatic cancer. Curr Probl Cancer 2002;26:176-275.
73. ERRANTE D, GABARRE J, RIDOLFO AL, ROSSI G, NOSARI AM, GISSELBRECHT C, KERNEIS Y, MAZZETTI F, VACCHER E, TALAMINI R, CARBONE A, TIRELLI U. Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF. Ann Oncol 1999;10:189-195.
74. GROGG KL, MILLER RF, DOGAN A. HIV infection and lymphoma. J Clin Pathol 2007;60:1365-1372.
75. TIRELLI U, ERRANTE D, DOLCETTI R, GLOGHINI A, SERRAINO D, VACCHER E, FRANCESCHI S, BOIOCCHI M, CARBONE A. Hodgkin's disease and human immunodefi ciency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and tumors. J Clin Oncol 1995;13:1758-1767.
76. POWLES T, ROBINSON D, STEBBING J, MELBYE M. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009;27:884-890.
77. BIGGAR RJ, HORM J, GOEDERT JJ, MELBYE M. Cancer in a group at risk of acquired immunodefi ciency syndrome (AIDS) through 1984. Am J Epidemiol 1987;126:578-586.
78. HESSOL NA, KATZ MH, LIU JY, BUCHBINDER SP, RUBINO CJ, HOLMBERG SD. Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med 1992;117:309-311.
79. SERRAINO D, CARBONE A, FRANCESCHI S, TIRELLI U. Increased frequency of lymphocyte depletion and mixed cellularity subtypes of Hodgkin disease in HIV-infected patients. Italian Cooperative Group on AIDS and Tumours. Eur J Cancer 1993;29A:1948-1950.
80. Serraino D, Pezzotti P, Dorrucci M, Alliegro MB, Sinicco A, Rezza G. Cancer incidence in a cohort of human immunodefi ciency virus seroconverters. HIV Italian Seroconverters Study Group. Cancer 1997;79:1004-1008.
81. FRANCESCHI S, DAL MASO L, ARNIANI S, CROSIGNANI P, VERCELLI M, SIMONATO L, FALCINI F, ZANETTI R, BARCHIELLI A, SERRAINO D, REZZA G. Risk of cancer other than Kaposi sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer 1998;78:966-970.
82. INTERNATIONAL COLLABORATION ON HIV AND CANCER. Highly active antiretroviral therapy and incidence of cancer in human immunodefi ciency virusinfectedadults. J Natl Cancer Inst 2000;92:1823-1830.
83. GRULICH AE, LI Y, MCDONALD A, CORRELL PK, LAW MG, KALDOR JM. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002;16:1155-1161.
84. DAL MASO L, FRANCESCHI S, POLESEL J, BRAGA C, PISELLI P, CROCETTI E, FALCINI F, GUZZINATI S, ZANETTI R, VERCELLI M, REZZA G; Cancer and AIDS Registy Linkage Study. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer 2003;89:94-100.
85. HERIDA M, MARY-KRAUSE M, KAPHAN R, CADRANEL J, POIZOT-MARTIN I, RABAUD C, PLAISANCE N, TISSOTDUPONT H, BOUE F, LANG JM, COSTAGLIOLA D. Incidence of non AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003;21:3447-3453.
86. BIGGAR RJ, JAFFE ES, GOEDERT JJ, CHATURVEDI A, PFEIFFER R, ENGELS EA. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006;108:3786-3791.
87. SERRAINO D, PISELLI P, BUSNACH G, BURRA P, CITTERIO F, ARBUSTINI E, BACCARANI U, DE JULI E, POZZETTO U, BELLELLI S, POLESEL J, PRADIER C, DAL MASO L, ANGELETTI C, CARRIERI MP, REZZA G, FRANCESCHI S; Immunosuppression and Cancer Study Group. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 2007;43:2117-2123.
88. ENGELS EA, BIGGAR RJ, HALL HI, CROSS H, CRUTCHFIELD A, FINCH JL, GRIGG R, HYLTON T, PAWLISH KS, MCNEEL TS, GOEDERT JJ. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008;123:187-194.
89. SEABERG EC, WILEY D, MARTÍNEZ-MAZA O, CHMIEL JS, KINGSLEY L, TANG Y, MARGOLICK JB, JACOBSON LP; Multicenter AIDS Cohort Study (MACS). Cancer incidence in the Multicenter AIDS Cohort Study before and during the HAART era: 1984-2007. Cancer 2010;116:5507-5516.
90. FRANCESCHI S, LISE M, CLIFFORD GM, RICKENBACH M, LEVI F, MASPOLI M, BOUCHARDY C, DEHLER S, JUNDT G, ESS S, BORDONI A, KONZELMANN I, FRICK H, DAL MASO L, ELZI L, FURRER H, CALMY A, CAVASSINI M, LEDERGERBER B, KEISER O; Swiss HIV Cohort Study. Changing patterns of cancer incidence in the early and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010;103:416-422.
91. BOHLIUS J, SCHMIDLIN K, BOUÉ F, FÄTKENHEUER G, MAY M, CARO-MURILLO AM, MOCROFT A, BONNET F, CLIFFORD G, PAPARIZOS V, MIRO JM, OBEL N, PRINS M, CHÊNE G, EGGER M; Collaboration of Observational HIV Epidemiological Research Europe. HIV related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ -cell lymphocytes. Blood 2011;117:6100-6108.
92. LANKY E, ROSENBERG PS, FILY F LASCAUX AS, MARTINEZ V, PARTISANI M, POIZOT-MARTIN I, ROUVEIX E, ENGELS EA, COSTAGLIOLA D, GOEDERT JJ; FHDH-ANRS CO4. HIV associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Blood 2011;118:44-49.
93. LEVINE AM. Hodgkin lymphoma: to the HAART of the matter. Blood 2006;108:3630.
94. GLOGHINI A, CARBONE A. Why would the incidence of HIV-associated Hodgkin lymphoma increase in the setting of improved immunity? Int J Cancer 2007;120:2753-2754.
95. CARBONE A, CABRAS A, GLOGHINI A. HIV associated Hodgkin's lymphoma. Antiapoptotic pathways and mechanisms for immune escape by tumor cells in the setting of improved immunity. Int J Biol Markers 2007;22:161-163.
96. DOLCETTI R, BOIOCCHI M, GLOGHINI A, CARBONE A. Pathogenetic and histogenetic features of HIVassociated Hodgkin's disease. Eur J Cancer 2001;37:1276-1287.
97. HENTRICH M, BERGER M, WYEN C, SIEHL J, ROCKSTROH JK, MÜLLER M, FÄTKENHEUER G, SEIDEL E, NICKELSEN M, WOLF T, RIEKE A, SCHÜRMANN D, SCHMIDMAIER R, PLANKER M, ALT J, MOSTHAF F, ENGERT A, ARASTEH K, HOFFMANN C. Stage adapted treatment of human immunodeficiency virus associated Hodgkin lymphoma: results of a prospective multicenter study. J Clin Oncol 2012;30:4117-4123.
98. LANDRIEU JM, ROITHMANN S, TOURANI JM, LEVY R, DESABLENS B, LE MAIGNAN C, GASTAUT JA, BRICE P, RAPHAEL M, TAILLAN B. Hodgkin's disease during HIV-1 infection: the French registry experience. Ann Oncol 1993;4:635-641.
99. RUBIO R. Disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cancer 1994;73:2400-2407.
100. MONTOTO S, SHAW K, OKOSUN J, GANDHI S, FIELDS P, WILSON A, SHANYINDE M, CWYNARSKI K, MARCUS R, DE VOS J, YOUNG AM, TENANT-FLOWERS M, ORKIN C, JOHNSON M, CHILTON D, GRIBBEN JG, BOWER M. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol 2012;30:4111-4116.
101. RIBERA J-M, NAVARRO JT, ORIOL A, LÓPEZ-GUILLERMO A, SUREDA A, ABELLA E, HERNÁNDEZ-RIVAS JA, XICOY B, GRAU J, BATLLE M, FELIU E. Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease. AIDS 2002;16:1973-1976.
102. GÉRARD L, GALICIER L, BOULANGER E, QUINT L, LEBRETTE MG, MORTIER E, MEIGNIN V, OKSENHENDLER E. Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy. AIDS 2003;17:81-87.
103. HOFFMANN C, CHOW KU, FAETKENHEUER G, STELLBRINK HJ, VAN LUNZEN J, JAEGER H, STOEHR A, PLETTENBERG A, WASMUTH JC, ROCKSTROH J, MOSTHAF F, HORST HA, BRODT HR. Strong impact of highly active antiretroviral therapy HIV-associated Hodgkin disease. Br J Haematol 2004;125:455-462.
104. HENTRICH M, MARETTA L, CHOW KU, BOGNER JR, SCHÜRMANN D, NEUHOFF P, JÄGER H, REICHELT D, VOGEL M, RUHNKE M, OETTE M, WEISS R, ROCKSTROH J, ARASTEH K, MITROU P. Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study. Ann Oncol 2006;17:914-919.
105. CHIMIENTI E, SPINA M, GASTALDI R ET AL. Clinical characteristics and outcome of 290 patients (pts) with Hodgkin's disease and HIV infection (HD-HIV) in pre and HAART (highly active antiretroviral therapy) era. Ann Oncol 2008;19:iv136, abstract 168.
106. BERENGUER J, MIRALLES P, RIBERA JM RUBIO R, VALENCIA E, MAHILLO B, PINTADO V, PALACIOS R, MONTES ML, TÉLLEZ MJ, LA CRUZ J, TORRE-CISNEROS J, RODRÍGUEZ-ARRONDO F, SEPÚLVEDA MA, GUTIÉRREZ F, PERALTA G, BOIX V. Characteristics and outcome of AIDS related Hodgkinlymphoma before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2008;47:422-428.
107. SPINA M, GABARRE J, ROSSI G, FASAN M, SCHIANTARELLI C, NIGRA E, MENA M, ANTINORI A, AMMASSARI A, TALAMINI R, VACCHER E, DI GENNARO G, TIRELLI U. Stanford V and concomitant HAART in 59 patients with Hodgkin's disease and HIV infection. Blood 2002;100:1984-1988.
108. SPINA M, ROSSI G, ANTINORI A, ET AL. VEBEP regimen and highly active antiretroviral therapy (HAART) in patients (pts) with HD and HIV infection (HD-HIV). Ann Oncol 2008;19:iv152, abstract 227.
109. GIACALONE A, SPINA M, BERRETTA M, TIRELLI U. Two types of fatigue in cancer patients. Br J Cancer 2012;106:424.
110. BERRETTA M, DI FRANCIA R, TIRELLI U. Editorial: The new oncologic challenges in the 3rd millennium. WCRJ 2014;1:e133.